Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NN-220 in Short Stature With Noonan Syndrome
NCT01927861Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2013
- Primary completion
- Jul 2018
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Noonan syndrome, sponsored by Novo Nordisk. Started Aug 2013; status: completed.
02
Drugs
somatropin
03
Conditions
Noonan syndrome
Beyond the preview
Go deeper on NCT01927861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01927861.